The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Research Report 2025

Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1728281

No of Pages : 94

Ask Your Query

Synopsis
Highlights
The global Streptococcus Pneumoniae Polysaccharide Vaccine market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
The major global manufacturers of Streptococcus Pneumoniae Polysaccharide Vaccine include Merck & Co.,Inc, Pfizer Inc, Glaxosmithkline Plc, Sanofi Pasteur, China National Biotec Group, Astellas Pharma Inc, Serum Institute of India Pvt. Ltd, Chengdu Institute of Biological Products Co., Ltd and Yuxi Watson Biotechnology Co., Ltd, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Single Dose Vial, which accounted for % of the global market of Streptococcus Pneumoniae Polysaccharide Vaccine in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Streptococcus Pneumoniae Polysaccharide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Streptococcus Pneumoniae Polysaccharide Vaccine.
The Streptococcus Pneumoniae Polysaccharide Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Streptococcus Pneumoniae Polysaccharide Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Streptococcus Pneumoniae Polysaccharide Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Some of the prominent players reviewed in the research report include:

  • Merck & Co.,Inc
  • Pfizer Inc
  • Glaxosmithkline Plc
  • Sanofi Pasteur
  • China National Biotec Group
  • Astellas Pharma Inc
  • Serum Institute of India Pvt. Ltd
  • Chengdu Institute of Biological Products Co., Ltd
  • Yuxi Watson Biotechnology Co., Ltd
  • Beijing Kexing Biological Products Co., Ltd
  • Beijing Minhai Biotechnology Co., Ltd

Product Type Insights
Global markets are presented by Streptococcus Pneumoniae Polysaccharide Vaccine type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Streptococcus Pneumoniae Polysaccharide Vaccine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Streptococcus Pneumoniae Polysaccharide Vaccine segment by Type

  • Single Dose Vial
  • Pre-Filled Syringe

Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Streptococcus Pneumoniae Polysaccharide Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Streptococcus Pneumoniae Polysaccharide Vaccine market.

Streptococcus Pneumoniae Polysaccharide Vaccine segment by Application

  • Hospital
  • Clinic

Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Streptococcus Pneumoniae Polysaccharide Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

  • This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Streptococcus Pneumoniae Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  • This report will help stakeholders to understand the global industry status and trends of Streptococcus Pneumoniae Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
  • This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
  • This report stays updated with novel technology integration, features, and the latest developments in the market
  • This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Streptococcus Pneumoniae Polysaccharide Vaccine industry.
  • This report helps stakeholders to gain insights into which regions to target globally
  • This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Streptococcus Pneumoniae Polysaccharide Vaccine.
  • This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Streptococcus Pneumoniae Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Streptococcus Pneumoniae Polysaccharide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.

Index

1 Streptococcus Pneumoniae Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of Streptococcus Pneumoniae Polysaccharide Vaccine
1.2 Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Type
1.2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Single Dose Vial
1.2.3 Pre-Filled Syringe
1.3 Streptococcus Pneumoniae Polysaccharide Vaccine Segment by Application
1.3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size Estimates and Forecasts
1.4.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue 2017-2028
1.4.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales 2017-2028
1.4.3 Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Streptococcus Pneumoniae Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Streptococcus Pneumoniae Polysaccharide Vaccine Market Competitive Situation and Trends
2.5.1 Streptococcus Pneumoniae Polysaccharide Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Streptococcus Pneumoniae Polysaccharide Vaccine Players Market Share by Revenue
2.5.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Streptococcus Pneumoniae Polysaccharide Vaccine Retrospective Market Scenario by Region
3.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Streptococcus Pneumoniae Polysaccharide Vaccine Market Facts & Figures by Country
3.3.1 North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country
3.3.2 North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Market Facts & Figures by Country
3.4.1 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country
3.4.2 Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region
3.5.2 Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Market Facts & Figures by Country
3.6.1 Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country
3.6.2 Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country
3.7.2 Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Streptococcus Pneumoniae Polysaccharide Vaccine Historic Market Analysis by Type
4.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type (2017-2022)
5 Global Streptococcus Pneumoniae Polysaccharide Vaccine Historic Market Analysis by Application
5.1 Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Merck & Co.,Inc
6.1.1 Merck & Co.,Inc Corporation Information
6.1.2 Merck & Co.,Inc Description and Business Overview
6.1.3 Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
6.1.5 Merck & Co.,Inc Recent Developments/Updates
6.2 Pfizer Inc
6.2.1 Pfizer Inc Corporation Information
6.2.2 Pfizer Inc Description and Business Overview
6.2.3 Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
6.2.5 Pfizer Inc Recent Developments/Updates
6.3 Glaxosmithkline Plc
6.3.1 Glaxosmithkline Plc Corporation Information
6.3.2 Glaxosmithkline Plc Description and Business Overview
6.3.3 Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
6.3.5 Glaxosmithkline Plc Recent Developments/Updates
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Corporation Information
6.4.2 Sanofi Pasteur Description and Business Overview
6.4.3 Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
6.4.5 Sanofi Pasteur Recent Developments/Updates
6.5 China National Biotec Group
6.5.1 China National Biotec Group Corporation Information
6.5.2 China National Biotec Group Description and Business Overview
6.5.3 China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
6.5.5 China National Biotec Group Recent Developments/Updates
6.6 Astellas Pharma Inc
6.6.1 Astellas Pharma Inc Corporation Information
6.6.2 Astellas Pharma Inc Description and Business Overview
6.6.3 Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
6.6.5 Astellas Pharma Inc Recent Developments/Updates
6.7 Serum Institute of India Pvt. Ltd
6.6.1 Serum Institute of India Pvt. Ltd Corporation Information
6.6.2 Serum Institute of India Pvt. Ltd Description and Business Overview
6.6.3 Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
6.7.5 Serum Institute of India Pvt. Ltd Recent Developments/Updates
6.8 Chengdu Institute of Biological Products Co., Ltd
6.8.1 Chengdu Institute of Biological Products Co., Ltd Corporation Information
6.8.2 Chengdu Institute of Biological Products Co., Ltd Description and Business Overview
6.8.3 Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
6.8.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments/Updates
6.9 Yuxi Watson Biotechnology Co., Ltd
6.9.1 Yuxi Watson Biotechnology Co., Ltd Corporation Information
6.9.2 Yuxi Watson Biotechnology Co., Ltd Description and Business Overview
6.9.3 Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
6.9.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
6.10 Beijing Kexing Biological Products Co., Ltd
6.10.1 Beijing Kexing Biological Products Co., Ltd Corporation Information
6.10.2 Beijing Kexing Biological Products Co., Ltd Description and Business Overview
6.10.3 Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
6.10.5 Beijing Kexing Biological Products Co., Ltd Recent Developments/Updates
6.11 Beijing Minhai Biotechnology Co., Ltd
6.11.1 Beijing Minhai Biotechnology Co., Ltd Corporation Information
6.11.2 Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Description and Business Overview
6.11.3 Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product Portfolio
6.11.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments/Updates
7 Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturing Cost Analysis
7.1 Streptococcus Pneumoniae Polysaccharide Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Streptococcus Pneumoniae Polysaccharide Vaccine
7.4 Streptococcus Pneumoniae Polysaccharide Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Streptococcus Pneumoniae Polysaccharide Vaccine Distributors List
8.3 Streptococcus Pneumoniae Polysaccharide Vaccine Customers
9 Streptococcus Pneumoniae Polysaccharide Vaccine Market Dynamics
9.1 Streptococcus Pneumoniae Polysaccharide Vaccine Industry Trends
9.2 Streptococcus Pneumoniae Polysaccharide Vaccine Market Drivers
9.3 Streptococcus Pneumoniae Polysaccharide Vaccine Market Challenges
9.4 Streptococcus Pneumoniae Polysaccharide Vaccine Market Restraints
10 Global Market Forecast
10.1 Streptococcus Pneumoniae Polysaccharide Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Streptococcus Pneumoniae Polysaccharide Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Streptococcus Pneumoniae Polysaccharide Vaccine by Type (2023-2028)
10.2 Streptococcus Pneumoniae Polysaccharide Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Streptococcus Pneumoniae Polysaccharide Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Streptococcus Pneumoniae Polysaccharide Vaccine by Application (2023-2028)
10.3 Streptococcus Pneumoniae Polysaccharide Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Streptococcus Pneumoniae Polysaccharide Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Streptococcus Pneumoniae Polysaccharide Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Streptococcus Pneumoniae Polysaccharide Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Streptococcus Pneumoniae Polysaccharide Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Streptococcus Pneumoniae Polysaccharide Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Streptococcus Pneumoniae Polysaccharide Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Streptococcus Pneumoniae Polysaccharide Vaccine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
Table 16. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Table 17. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
Table 19. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 20. North America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 21. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 23. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 24. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 25. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 33. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 40. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Type (2017-2022)
Table 41. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Type (2017-2022)
Table 43. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units) by Application (2017-2022)
Table 45. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Application (2017-2022)
Table 46. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Application (2017-2022)
Table 48. Global Streptococcus Pneumoniae Polysaccharide Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 49. Merck & Co.,Inc Corporation Information
Table 50. Merck & Co.,Inc Description and Business Overview
Table 51. Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Merck & Co.,Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product
Table 53. Merck & Co.,Inc Recent Developments/Updates
Table 54. Pfizer Inc Corporation Information
Table 55. Pfizer Inc Description and Business Overview
Table 56. Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Pfizer Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product
Table 58. Pfizer Inc Recent Developments/Updates
Table 59. Glaxosmithkline Plc Corporation Information
Table 60. Glaxosmithkline Plc Description and Business Overview
Table 61. Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Glaxosmithkline Plc Streptococcus Pneumoniae Polysaccharide Vaccine Product
Table 63. Glaxosmithkline Plc Recent Developments/Updates
Table 64. Sanofi Pasteur Corporation Information
Table 65. Sanofi Pasteur Description and Business Overview
Table 66. Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Sanofi Pasteur Streptococcus Pneumoniae Polysaccharide Vaccine Product
Table 68. Sanofi Pasteur Recent Developments/Updates
Table 69. China National Biotec Group Corporation Information
Table 70. China National Biotec Group Description and Business Overview
Table 71. China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. China National Biotec Group Streptococcus Pneumoniae Polysaccharide Vaccine Product
Table 73. China National Biotec Group Recent Developments/Updates
Table 74. Astellas Pharma Inc Corporation Information
Table 75. Astellas Pharma Inc Description and Business Overview
Table 76. Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Astellas Pharma Inc Streptococcus Pneumoniae Polysaccharide Vaccine Product
Table 78. Astellas Pharma Inc Recent Developments/Updates
Table 79. Serum Institute of India Pvt. Ltd Corporation Information
Table 80. Serum Institute of India Pvt. Ltd Description and Business Overview
Table 81. Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Serum Institute of India Pvt. Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product
Table 83. Serum Institute of India Pvt. Ltd Recent Developments/Updates
Table 84. Chengdu Institute of Biological Products Co., Ltd Corporation Information
Table 85. Chengdu Institute of Biological Products Co., Ltd Description and Business Overview
Table 86. Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Chengdu Institute of Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product
Table 88. Chengdu Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 89. Yuxi Watson Biotechnology Co., Ltd Corporation Information
Table 90. Yuxi Watson Biotechnology Co., Ltd Description and Business Overview
Table 91. Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Yuxi Watson Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product
Table 93. Yuxi Watson Biotechnology Co., Ltd Recent Developments/Updates
Table 94. Beijing Kexing Biological Products Co., Ltd Corporation Information
Table 95. Beijing Kexing Biological Products Co., Ltd Description and Business Overview
Table 96. Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Beijing Kexing Biological Products Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product
Table 98. Beijing Kexing Biological Products Co., Ltd Recent Developments/Updates
Table 99. Beijing Minhai Biotechnology Co., Ltd Corporation Information
Table 100. Beijing Minhai Biotechnology Co., Ltd Description and Business Overview
Table 101. Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Beijing Minhai Biotechnology Co., Ltd Streptococcus Pneumoniae Polysaccharide Vaccine Product
Table 103. Beijing Minhai Biotechnology Co., Ltd Recent Developments/Updates
Table 104. Production Base and Market Concentration Rate of Raw Material
Table 105. Key Suppliers of Raw Materials
Table 106. Streptococcus Pneumoniae Polysaccharide Vaccine Distributors List
Table 107. Streptococcus Pneumoniae Polysaccharide Vaccine Customers List
Table 108. Streptococcus Pneumoniae Polysaccharide Vaccine Market Trends
Table 109. Streptococcus Pneumoniae Polysaccharide Vaccine Market Drivers
Table 110. Streptococcus Pneumoniae Polysaccharide Vaccine Market Challenges
Table 111. Streptococcus Pneumoniae Polysaccharide Vaccine Market Restraints
Table 112. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 113. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 114. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 115. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 116. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 117. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 118. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 119. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 120. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 121. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 122. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 123. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Streptococcus Pneumoniae Polysaccharide Vaccine
Figure 2. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Type in 2021 & 2028
Figure 3. Single Dose Vial Product Picture
Figure 4. Pre-Filled Syringe Product Picture
Figure 5. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Size (2017-2028) & (US$ Million)
Figure 10. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales (2017-2028) & (K Units)
Figure 11. Streptococcus Pneumoniae Polysaccharide Vaccine Sales Share by Manufacturers in 2021
Figure 12. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Streptococcus Pneumoniae Polysaccharide Vaccine Players: Market Share by Revenue in 2021
Figure 14. Streptococcus Pneumoniae Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Figure 16. Global Streptococcus Pneumoniae Polysaccharide Vaccine Sales Market Share by Region in 2021
Figure 17. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
Figure 18. Global Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Market Share by Region in 2021
Figure 19. United States Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Taiwan Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Mexico Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Brazil Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Argentina Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Colombia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Streptococcus Pneumoniae Polysaccharide Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Streptococcus Pneumoniae Polysaccharide Vaccine by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Streptococcus Pneumoniae Polysaccharide Vaccine
Figure 44. Manufacturing Process Analysis of Streptococcus Pneumoniae Polysaccharide Vaccine
Figure 45. Streptococcus Pneumoniae Polysaccharide Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock